These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23121543)

  • 1. Agraphia in patients with frontotemporal dementia and parkinsonism linked to chromosome 17 with P301L MAPT mutation: dysexecutive, aphasic, apraxic or spatial phenomenon?
    Sitek EJ; Narozanska E; Barczak A; Jasinska-Myga B; Harciarek M; Chodakowska-Zebrowska M; Kubiak M; Wieczorek D; Konieczna S; Rademakers R; Baker M; Berdynski M; Brockhuis B; Barcikowska M; Zekanowski C; Heilman KM; Wszolek ZK; Slawek J
    Neurocase; 2014; 20(1):69-86. PubMed ID: 23121543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features.
    Ikeda A; Shimada H; Nishioka K; Takanashi M; Hayashida A; Li Y; Yoshino H; Funayama M; Ueno Y; Hatano T; Sahara N; Suhara T; Higuchi M; Hattori N
    Mov Disord; 2019 Apr; 34(4):568-574. PubMed ID: 30773680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation.
    Morino H; Kurashige T; Matsuda Y; Ono M; Sahara N; Miyasaka T; Soeda Y; Shimada H; Yamazaki Y; Takahashi T; Izumi Y; Ito H; Maruyama H; Higuchi M; Arihiro K; Suhara T; Takashima A; Kawakami H
    Mov Disord Clin Pract; 2024 Jun; 11(6):720-727. PubMed ID: 38605589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical, pathological, and genetic characteristics of frontotemporal dementia and parkinsonism linked to chromosome 17 with mutations in the MAPT and PGRN].
    Tsuboi Y
    Brain Nerve; 2009 Nov; 61(11):1285-91. PubMed ID: 19938685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
    Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
    Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontotemporal dementia and parkinsonism linked to chromosome 17--the first Polish family.
    Narożańska E; Jasińska-Myga B; Sitek EJ; Robowski P; Brockhuis B; Lass P; Dubaniewicz M; Wieczorek D; Baker M; Rademakers R; Wszolek ZK; Sławek J
    Eur J Neurol; 2011 Mar; 18(3):535-7. PubMed ID: 20561037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Genetic Study of the First Japanese FTDP-17 Patient with a Mutation of +3 in Intron 10 in the MAPT Gene.
    Nan H; Takaki R; Shimozono K; Ichinose Y; Koh K; Takiyama Y
    Intern Med; 2019 Aug; 58(16):2397-2400. PubMed ID: 30996196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation.
    Boeve BF; Tremont-Lukats IW; Waclawik AJ; Murrell JR; Hermann B; Jack CR; Shiung MM; Smith GE; Nair AR; Lindor N; Koppikar V; Ghetti B
    Brain; 2005 Apr; 128(Pt 4):752-72. PubMed ID: 15615814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontotemporal dementia with Parkinsonism linked to chromosome-17 mutations enhance tau oligomer formation.
    Maeda S; Sato Y; Takashima A
    Neurobiol Aging; 2018 Sep; 69():26-32. PubMed ID: 29852407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAPT mutation associated with frontotemporal dementia and parkinsonism (FTDP-17).
    Haussmann R; Wysocki M; Brandt MD; Hermann A; Donix M
    Int Psychogeriatr; 2017 May; 29(5):869-871. PubMed ID: 27905268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9/exon 10 of the MAPT gene.
    Olszewska DA; Fearon C; McGuigan C; McVeigh TP; Houlden H; Polke JM; Lawlor B; Coen R; Hutchinson M; Hutton M; Beausang A; Delon I; Brett F; Sevastou I; Seto-Salvia N; de Silva R; Lynch T
    Neurobiol Aging; 2021 Oct; 106():343.e1-343.e8. PubMed ID: 34274155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset.
    Wu L; Liu J; Feng X; Dong J; Qin W; Liu Y; Wang J; Lu J; Chen K; Wang Y; Jia J
    J Alzheimers Dis; 2018; 61(2):613-618. PubMed ID: 29226866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting genotypes of the tau gene in two phenotypically distinct patients with P301L mutation of frontotemporal dementia and parkinsonism linked to chromosome 17.
    Kobayashi T; Mori H; Okuma Y; Dickson DW; Cookson N; Tsuboi Y; Motoi Y; Tanaka R; Miyashita N; Anno M; Narabayashi H; Mizuno Y
    J Neurol; 2002 Jun; 249(6):669-75. PubMed ID: 12111297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN).
    Boeve BF; Hutton M
    Arch Neurol; 2008 Apr; 65(4):460-4. PubMed ID: 18413467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetic features of families with frontotemporal dementia and parkinsonism linked to chromosome 17 with a P301S tau mutation.
    Baba Y; Baker MC; Le Ber I; Brice A; Maeck L; Kohlhase J; Yasuda M; Stoppe G; Bugiani O; Sperfeld AD; Tsuboi Y; Uitti RJ; Farrer MJ; Ghetti B; Hutton ML; Wszolek ZK
    J Neural Transm (Vienna); 2007 Jul; 114(7):947-50. PubMed ID: 17318302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.
    Gatto EM; Allegri RF; Da Prat G; Chrem Mendez P; Hanna DS; Dorschner MO; Surace EI; Zabetian CP; Mata IF
    Neurobiol Aging; 2017 May; 53():195.e11-195.e17. PubMed ID: 28268100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia.
    Momeni P; Wickremaratchi MM; Bell J; Arnold R; Beer R; Hardy J; Revesz T; Neal JW; Morris HR
    Clin Neurol Neurosurg; 2010 Dec; 112(10):917-20. PubMed ID: 20708332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease.
    Shiarli AM; Jennings R; Shi J; Bailey K; Davidson Y; Tian J; Bigio EH; Ghetti B; Murrell JR; Delisle MB; Mirra S; Crain B; Zolo P; Arima K; Iseki E; Murayama S; Kretzschmar H; Neumann M; Lippa C; Halliday G; Mackenzie J; Khan N; Ravid R; Dickson D; Wszolek Z; Iwatsubo T; Pickering-Brown SM; Mann DM
    Neuropathol Appl Neurobiol; 2006 Aug; 32(4):374-87. PubMed ID: 16866983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
    Wszolek ZK; Tsuboi Y; Ghetti B; Pickering-Brown S; Baba Y; Cheshire WP
    Orphanet J Rare Dis; 2006 Aug; 1():30. PubMed ID: 16899117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and postmortem clinicoanatomical correlations in frontotemporal dementia and parkinsonism linked to chromosome 17.
    Ghetti B; Spina S; Murrell JR; Huey ED; Pietrini P; Sweeney B; Wassermann EM; Keohane C; Farlow MR; Grafman J
    Neurodegener Dis; 2008; 5(3-4):215-7. PubMed ID: 18322394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.